Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies

NCT00038883 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Lymphocytic, Chronic
Leukemia, Lymphocytic, Acute
Lymphoma, Low-Grade
Lymphoma, T-Cell
Lymphoma, B-Cell

Interventions

DRUG: Campath-1H

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]